Brief: Adc Therapeutics Q4 Cash And Cash Equivalents Were $466.5 Mln

ADC Therapeutics SA

03/03/2022 13:05

March 3 (Reuters) - ADC Therapeutics SA  ADCT.N :
    * CASH AND CASH EQUIVALENTS WERE $466.5 MILLION AS OF
DECEMBER 31,
2021, COMPARED TO $439.2 MILLION AS OF DECEMBER 31, 2020

Source text for Eikon:  ID:nBw9KvNJCa 
Further company coverage:  ADCT.N 

 ((Reuters.Briefs@thomsonreuters.com;))